BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28921546)

  • 1. Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression.
    Rifatbegovic F; Frech C; Abbasi MR; Taschner-Mandl S; Weiss T; Schmidt WM; Schmidt I; Ladenstein R; Ambros IM; Ambros PF
    Int J Cancer; 2018 Jan; 142(2):297-307. PubMed ID: 28921546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.
    Rifatbegovic F; Abbasi MR; Taschner-Mandl S; Kauer M; Weinhäusel A; Handgretinger R; Ambros PF
    PLoS One; 2015; 10(9):e0137995. PubMed ID: 26360775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers.
    Merugu S; Chen L; Gavens E; Gabra H; Brougham M; Makin G; Ng A; Murphy D; Gabriel AS; Robinson ML; Wright JH; Burchill SA; Humphreys A; Bown N; Jamieson D; Tweddle DA
    Clin Cancer Res; 2020 Jan; 26(1):122-134. PubMed ID: 31767563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.
    Abbasi MR; Rifatbegovic F; Brunner C; Mann G; Ziegler A; Pötschger U; Crazzolara R; Ussowicz M; Benesch M; Ebetsberger-Dachs G; Chan GCF; Jones N; Ladenstein R; Ambros IM; Ambros PF
    Clin Cancer Res; 2017 Aug; 23(15):4224-4232. PubMed ID: 28228384
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.
    Abbasi MR; Rifatbegovic F; Brunner C; Ladenstein R; Ambros IM; Ambros PF
    Mol Oncol; 2015 Mar; 9(3):545-54. PubMed ID: 25467309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
    Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
    Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.
    Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B
    Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
    Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
    Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.
    Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R
    Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients.
    Wimberger P; Roth C; Pantel K; Kasimir-Bauer S; Kimmig R; Schwarzenbach H
    Int J Cancer; 2011 Jun; 128(11):2572-80. PubMed ID: 20715113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
    Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R
    Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
    Rack B; Zombirt E; Trapp E; Jückstock J; Andergassen U; Neugebauer J; Kost B; Weissenbacher T; Jeschke U; Schindlbeck C; Janni W; Alunni-Fabbroni M
    Oncology; 2016; 90(4):232-8. PubMed ID: 26937631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
    Demeulemeester J; Kumar P; Møller EK; Nord S; Wedge DC; Peterson A; Mathiesen RR; Fjelldal R; Zamani Esteki M; Theunis K; Fernandez Gallardo E; Grundstad AJ; Borgen E; Baumbusch LO; Børresen-Dale AL; White KP; Kristensen VN; Van Loo P; Voet T; Naume B
    Genome Biol; 2016 Dec; 17(1):250. PubMed ID: 27931250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
    Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
    Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
    Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
    J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
    Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
    Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.
    Stigliani S; Scaruffi P; Lagazio C; Persico L; Carlini B; Varesio L; Morandi F; Morini M; Gigliotti AR; Esposito MR; Viscardi E; Cecinati V; Conte M; Corrias MV
    Oncotarget; 2015 May; 6(15):13295-308. PubMed ID: 25980492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
    Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
    Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.